Literature DB >> 23299340

[Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients].

T Wilke1, P Ahrendt, D Schwartz, R Linder, S Ahrens, F Verheyen.   

Abstract

BACKGROUND AND
OBJECTIVE: Based on claims-data of 5.43 million members of a large German statutory health insurance fund in 2008 (Techniker Krankenkasse), the aim of this contribution is to update and more precisely quantify age- and gender-specific prevalence and incidence of type 2 diabetes mellitus (T2DM) in a German setting.
METHODS: A patient was classified as T2DM prevalent if he or she had received at least two outpatient diagnoses of T2DM in two different quarters of the year and/or had received at least one T2DM diagnosis during inpatient treatment between 01/01/2006 and 12/31/2008. A patient was considered to have had new onset T2DM in 2008 under one of three conditions: 1. no diagnosis of T2DM in 2006 and 2007, 2. no presripction of oral antidiabetics in 2006 and 2007, 3. either one inpatient or two outpatient diagnoses of T2DM conducted in two different quarters of 2008 or one outpatient T2DM diagnosis in 2006/07 when the second diagnosis was made in 2008.
RESULTS: A total of 254,524 patients had T2DM. Compared to the total membership of the medical insurance fund, the prevalence of T2DM was 4.69 %. The average age was 64.8 years, and 66.37 % were male. The incidence of T2DM in our sample was 2.814 cases per 1,000 person-years in men and 1.690 cases in 1,000 person-years in women. Based on our sample and on official population data, 4,704,585 patients (5.75 %) in Germany would be T2DM prevalent in 2009. The number of incident T2DM cases would amount to 215,746 patients (0.264 %).
CONCLUSIONS: T2DM is one of the most common chronic diseases in Germany. The expected demographic changes in Germany will increase the burden on the German health system caused by T2DM. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23299340     DOI: 10.1055/s-0032-1327394

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  14 in total

1.  Predictors of non-drug psychiatric/psychotherapeutic treatment in children and adolescents with mental or behavioural disorders.

Authors:  Sascha Abbas; Peter Ihle; Jürgen-Bernhard Adler; Susanne Engel; Christian Günster; Martin Holtmann; Axel Kortevoss; Roland Linder; Werner Maier; Gerd Lehmkuhl; Ingrid Schubert
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-14       Impact factor: 4.785

2.  The Prevalence and Incidence of Diabetes in Germany.

Authors:  Teresa Tamayo; Ralph Brinks; Annika Hoyer; Oliver S Kuß; Wolfgang Rathmann
Journal:  Dtsch Arztebl Int       Date:  2016-03-18       Impact factor: 5.594

3.  Costing of diabetes mellitus type II in Cambodia.

Authors:  Steffen Flessa; Anika Zembok
Journal:  Health Econ Rev       Date:  2014-11-01

4.  Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.

Authors:  Teresa Tamayo; Sabine Schipf; Christine Meisinger; Michaela Schunk; Werner Maier; Christian Herder; Michael Roden; Matthias Nauck; Annette Peters; Henry Völzke; Wolfgang Rathmann
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  Early diagnosis of diabetic retinopathy in primary care.

Authors:  Maria Valeria Jimenez-Baez; Horacio Marquez-Gonzalez; Rodolfo Barcenas-Contreras; Carlos Morales Montoya; Laura Fatima Espinosa-Garcia
Journal:  Colomb Med (Cali)       Date:  2015-03-30

6.  Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.

Authors:  Michael W J Boehme; Gisela Buechele; Julia Frankenhauser-Mannuss; Jana Mueller; Dietlinde Lump; Bernhard O Boehm; Dietrich Rothenbacher
Journal:  BMC Public Health       Date:  2015-09-03       Impact factor: 3.295

7.  Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study.

Authors:  Muhammad Sadik Memon; Zain Islam Arain; Farukh Naz; Madiha Zaki; Suresh Kumar; Asif Ali Burney
Journal:  J Diabetes Res       Date:  2013-08-01       Impact factor: 4.011

8.  Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011.

Authors:  Carola A Huber; Matthias Schwenkglenks; Roland Rapold; Oliver Reich
Journal:  BMC Endocr Disord       Date:  2014-06-03       Impact factor: 2.763

9.  Effect of sericin on diabetic hippocampal growth hormone/insulin-like growth factor 1 axis.

Authors:  Zhihong Chen; Songhe Yang; Yaqiang He; Chengjun Song; Yongping Liu
Journal:  Neural Regen Res       Date:  2013-07-05       Impact factor: 5.135

Review 10.  SGLT2 inhibitors - an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin.

Authors:  Jochen Seufert
Journal:  Diabetes Metab Syndr Obes       Date:  2015-11-09       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.